Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort study
Modern Rheumatology · 2025
DOI: 10.1093/mr/roaf129 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Masatoshi Kawai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Lupus Nephritis, Kidney. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To clarify long-term prognosis and its relevant factors in patients with pure class V lupus nephritis (LN).
Methods
We reviewed consecutive patients with biopsy-proven pure class V LN from KEIO-SLE cohort. The treatment target and deep remission (DR) were defined as urine protein-to-creatinine ratio <0.7 g/gCr and <0.15 g/gCr, respectively. Patients were divided into two groups based on the occurrence of renal flare, and baseline clinical and pathological characteristics were compared.
Results
Thirty patients with pure class V LN were included. All patients achieved the treatment target. Among them, seven patients (23.3%) experienced renal flare. In the Firth’s penalized Cox regression analysis, univariate analysis showed that smoking history, glucocorticoid monotherapy throughout follow-up, anti-ribonucleoprotein antibody positivity, Chronicity index ≥3, and non-achievement of DR were associated with an increased risk of renal flare. Multivariable analysis revealed that only non-achievement of DR remained an independent risk factor. Kaplan–Meier analyses showed significantly lower flare-free survival in patients with these risk factors. No patients developed end-stage kidney disease during a median observation period of 85.6 months.
Conclusion
Overall long-term prognosis of pure class V LN was favourable. However, approximately one-quarter of patients experienced renal flares. Failure to achieve DR, smoking history, throughout glucocorticoid monotherapy, and anti-ribonucleoprotein antibody positivity were associated with an increased risk of renal flare, with failure to achieve DR being the only independent risk factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Masatoshi Kawai, Hironari Hanaoka
Zitieren
APA
Kawai, M., Hanaoka, H., Fukui, H., Suzuki, K., Hiramoto, K., Takei, H., Kikuchi, J., & Kaneko, Y. (2025). Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort study. Modern Rheumatology. https://doi.org/10.1093/mr/roaf129
Vancouver
Kawai M, Hanaoka H, Fukui H, Suzuki K, Hiramoto K, Takei H, et al. Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort study. Modern Rheumatology. 2025. doi:10.1093/mr/roaf129
BibTeX
@article{Kawai2025,
author = {Kawai, Masatoshi and Hanaoka, Hironari and Fukui, Hiroyuki and Suzuki, Koji and Hiramoto, Kazuoto and Takei, Hiroshi and Kikuchi, Jun and Kaneko, Yuko},
title = {Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort study},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roaf129}
}
EUVIMED